
    
      To evaluate the efficacy of valsartan, added to standard AF therapy, to maintain sinus rhythm
      and extend the interval to first AF recurrence after cardioversion.Evaluate the efficacy of
      valsartan, begun prior to cardioversion, on the difficulty (number and total energy of CV
      attempts), the net rate of cardioversion (to SR for >10 minutes), and early AF recurrence
      rate (within 24 hours)
    
  